诱导自作为NAFLD的治疗突破:目前的证据和前景
Yanke Liu1, Mingkang Zhang2, Yazhi Wang3
1Department of Laboratory Medicine, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou 730000, China.
Biology
|September 4, 2025
概括
非酒精性脂肪肝 (NAFLD) 与自功能受损有关. 恢复这种细胞过程对治疗NAFLD有希望, 目前正在研究各种治疗干预措施.
科学领域:
- 细胞生物学
- 肝病学
- 分子医学
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是全球普遍存在的导致肝功能障碍的健康问题.
- 导致NAFLD进展的确切机制尚未完全理解.
- 自是一种细胞循环过程,越来越多地涉及到NAFLD的发病.
研究的目的:
- 审查自和NAFLD之间的复杂关系.
- 探索针对NAFLD治疗的当前和新兴治疗策略.
- 确定新型NAFLD治疗的潜在分子点.
主要方法:
- 对研究NAFLD自的综合文献综述.
- 对各种干预措施的研究分析,包括生活方式,药物学和其他新的方法.
- 讨论分子机制和潜在的治疗点.
主要成果:
- 证据强烈地将受损的自与NAFLD的发展和进展联系在一起.
- 恢复自功能是减轻肝损伤的潜在策略.
- 目前正在探索各种干预措施,从饮食到植物性化合物,以调节NAFLD的自性.
结论:
- 自在NAFLD病理生理学中起着核心作用.
- 针对自是一种有希望的NAFLD治疗途径,但仍存在挑战.
- 进一步研究与自相关的分子点对于开发有效的NAFLD疗法至关重要.
相关概念视频
Delivery Pathways to the Lysosome
7.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K
Autophagy
5.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.1K
Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
NF-κB-dependent Signaling Pathway
7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.7K
Autophagic Cell Death
3.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


